A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone

Prostate cancer is unique in that bone is often the only clinically detectable site of metastasis. Prostate tumors that have metastasized to bone frequently induce bone pain which can be difficult to fully control as it seems to be driven simultaneously by inflammatory, neuropathic, and tumorigenic...

Ausführliche Beschreibung